D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
CALL
Chegg
CHGG
$108M
| $19.7M | 0.03% |
550,000
| – | – |
|
|
602
CALL
Pfizer
PFE
$140B
| $19.7M | 0.03% |
635,246
-1,178,793
| -65% | -$40.2M |
|
|
XLRN
603
DELISTED
Acceleron Pharma
XLRN
| $19.7M | 0.03% |
+218,866
| New | +$17M |
|
604
The Mosaic Company
MOS
$7.09B
| $19.6M | 0.03% |
1,815,801
-1,927,619
| -51% | -$32.7M |
|
|
NEE.PRP
605
DELISTED
NextEra Energy, Inc. 5.279% Corporate Units
NEE.PRP
| $19.6M | 0.03% |
+450,000
| New | +$18.9M |
|
606
Green Dot
GDOT
$753M
| $19.6M | 0.03% |
771,892
-638,822
| -45% | -$18.4M |
|
607
CALL
Chevron
CVX
$388B
| $19.6M | 0.03% |
270,400
-453,900
| -63% | -$44.9M |
|
608
SiteOne Landscape Supply
SITE
$4.43B
| $19.5M | 0.03% |
265,301
+32,802
| +14% | +$3M |
|
609
Arrowhead Research
ARWR
$12.1B
| $19.5M | 0.03% |
676,121
-16,774
| -2% | -$676K |
|
610
PBF Energy
PBF
$7.29B
| $19.4M | 0.03% |
2,743,569
+1,969,890
| +255% | +$44.2M |
|
611
PUT
Paycom
PAYC
$6.78B
| $19.3M | 0.03% |
95,600
+39,700
| +71% | +$10.9M |
|
612
Vanguard Global ex-US Real Estate ETF
VNQI
$3.46B
| $19.3M | 0.03% |
449,233
-800,683
| -64% | -$43.1M |
|
613
Freshpet
FRPT
$2.83B
| $19.2M | 0.03% |
300,690
+38,779
| +15% | +$2.49M |
|
614
CALL
Blackrock
BLK
$164B
| $19.2M | 0.03% |
43,600
-23,100
| -35% | -$11.4M |
|
615
PUT
PepsiCo
PEP
$186B
| $19.2M | 0.03% |
159,600
+36,700
| +30% | +$4.96M |
|
616
Chubb
CB
$140B
| $19.1M | 0.03% |
171,063
+169,319
| +9,709% | +$24.3M |
|
|
MGLN
617
DELISTED
Magellan Health Services, Inc.
MGLN
| $19.1M | 0.03% |
396,167
-7,494
| -2% | -$482K |
|
618
CALL
Berkshire Hathaway Class B
BRK.B
$1.07T
| $18.9M | 0.03% |
103,500
-192,000
| -65% | -$40.8M |
|
619
Avnet
AVT
$7.33B
| $18.9M | 0.03% |
753,063
-69,872
| -8% | -$2.38M |
|
|
CFXA
620
DELISTED
Colfax Corporation 5.75% Tangible Equity Units
CFXA
| $18.9M | 0.03% |
205,000
-10,000
| -5% | -$1.39M |
|
621
Regeneron Pharmaceuticals
REGN
$68.8B
| $18.8M | 0.03% |
38,588
-41,893
| -52% | -$17.3M |
|
|
CCI.PRA
622
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
| $18.8M | 0.03% |
14,500
| – | – |
|
623
CALL
AbbVie
ABBV
$458B
| $18.8M | 0.03% |
246,700
-616,300
| -71% | -$52.5M |
|
624
CALL
General Motors
GM
$74.7B
| $18.8M | 0.03% |
903,300
-197,900
| -18% | -$6.04M |
|
|
625
PUT
Biogen
BIIB
$29.9B
| $18.8M | 0.03% |
59,300
-78,400
| -57% | -$23.8M |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.